FREE TRIAL OFFER. CLICK HERE.

  • Home
  • Performance
    • Director's Letter
    • Historical
    • Monthly Index
  • Research
    • Announcements
    • High Performance Quant Screens
    • Smart Screens
      • Shorts
    • Conferences
  • Complimentary Reports
  • Discover
    • Best Calls
    • Presentation
  • About Us
    • SingularResearch.com Disclaimer
    • Announcements
    • Accredited Investor Disclaimer
    • Latest Updates
  • Calendar
  • Log In
  • Shop
    • Complimentary Subscription Sign Up
    • Quarterly Research Subscription
    • Annual Research Subscription
  • Cart

  • Home
  • Performance
    • Director's Letter
    • Historical
    • Monthly Index
  • Research
    • Announcements
    • High Performance Quant Screens
    • Smart Screens
      • Shorts
    • Conferences
  • Complimentary Reports
  • Discover
    • Best Calls
    • Presentation
  • About Us
    • SingularResearch.com Disclaimer
    • Announcements
    • Accredited Investor Disclaimer
    • Latest Updates
  • Calendar
  • Log In
  • Shop
    • Complimentary Subscription Sign Up
    • Quarterly Research Subscription
    • Annual Research Subscription
  • Cart

Trial Offer

Harvard Bioscience (HBIO:BUY) HBIO delivers a strong start to the year with 48% year-over-year revenues growth

Written by Super User on 15 May 2018.

IEC Electronics Corporation (IEC:DROP) Terminating coverage in order to focus resources elsewhere.

Written by Super User on 22 April 2014.

Innovative Solutions and Support, Inc. (ISSC:BUY) Revenue beat largely due to record Engineering sales.

Written by Super User on 24 April 2014.

IntelGenx Technologies Corp. (IGXT:DROP) Dropping coverage. Lack of transparency, institutional interest

Written by Super User on 10 May 2018.

IRIDEX (IRIX:BUY) Robust sales of proprietary new ophthalmic laser, amplified by high recurring sales of disposable laser probes, fueled 32% sales growth

Written by Super User on 10 August 2016.

JMP Group (JMP:BUY) The company announced better-than expected first quarter 2018 revenues while earnings were below our estimates.

Written by Super User on 15 May 2018.

JMP Group (JMP:BUY) The company announced better-than expected second quarter 2018 results with both revenue and earnings above our estimates.

Written by Super User on 03 August 2018.

JMP Group (JMP:BUY) With the equity capital markets still at very depressed levels through Q2:16, JMP’s diversified business model delivered operating earnings of $0.10

Written by Super User on 12 August 2016.

Kulicke and Soffa (KLIC:BUY-LT) The company beat our revenue and adjusted EPS estimate easily, as revenue surged

Written by Super User on 24 August 2018.

Kulicke and Soffa (KLIC:BUY-LT) The company released provisional revenue and EPS figures for Q2:18, but is holding off on a full release

Written by Super User on 11 May 2018.

LSI Industries, Inc. (LYTS:BUY) Q3:14 revenues and EPS below our expectations largely due to sales decline in Graphics segment.

Written by Super User on 29 April 2014.

LSI Industries, Inc. (LYTS:BUY) The company announced subdued third quarter results with revenues increasing marginally by 1.0% to $78.8 million

Written by Super User on 10 May 2018.

Manitex International (MNTX:BUY) Solid finish to 2013 and end markets appear to be improving as backlog begins to climb.

Written by Super User on 29 April 2014.

Multi-Color Corp (LABL:BUY) Q1:17 Adjusted EPS of $0.95 beats our estimate of $0.88 on a higher than expected gross margin

Written by Super User on 10 August 2016.

Newtek Business Services (NEWT:BUY) Loan funding up 40.7% in Q2:16. NEWT closes acquisition of bank-serv Partners for 4.3x forecasted EBITDA.

Written by Super User on 12 August 2016.

Newtek Business Services (NEWT:BUY) SBA 7(a) loans rise 27% through April to a record $109.8 million.

Written by Super User on 10 May 2018.

Newtek Business Services (NEWT:DROP) After a near 550% accent for our clients since initiating coverage in early 2013, we think the outlook remains bright

Written by Super User on 27 August 2018.

NV 5 Global (NVEE:BUY Long-term) NVEE announced better-than expected Q2:18 results with revenue up 24%

Written by Super User on 05 September 2018.

NV 5 Global (NVEE:BUY) Q2 Revenues increased 62% over the prior year, boosted by acquisitions.

Written by Super User on 15 August 2015.

NV 5 Global (NVEE:BUY) The Company announced better-than expected Q1:18 adjusted EPS, increasing 51% YOY to $0.59.

Written by Super User on 15 May 2018.

  • 1
  • 2
  • 3
  • 4
Powered by Warp Theme Framework
  • Home
  • Performance
    • Director's Letter
    • Historical
    • Monthly Index
  • Research
    • Announcements
    • High Performance Quant Screens
    • Smart Screens
      • Shorts
    • Conferences
  • Complimentary Reports
  • Discover
    • Best Calls
    • Presentation
  • About Us
    • SingularResearch.com Disclaimer
    • Announcements
    • Accredited Investor Disclaimer
    • Latest Updates
  • Calendar
  • Log In
  • Shop
    • Complimentary Subscription Sign Up
    • Quarterly Research Subscription
    • Annual Research Subscription
  • Cart